Id |
Subject |
Object |
Predicate |
Lexical cue |
T338 |
0-10 |
Sentence |
denotes |
Discussion |
T339 |
11-256 |
Sentence |
denotes |
In this observational prospective multicentre study, we report the characteristics, early outcome and management of the COVID-19 outbreak on the largest European cohort of liver transplant patients with confirmed SARS-CoV-2 infection up to date. |
T340 |
257-405 |
Sentence |
denotes |
Case fatality rate of the overall study population was 12% (95% CI 5% to 24%), whereas that of the hospitalised patients was 17% (95% CI 7% to 32%). |
T341 |
406-630 |
Sentence |
denotes |
This latter is in line with that of the general population, as reported by most of the largest studies, where the in-hospital case fatality rate ranges from 15% to 22%.1 25 26 All the patients who died, except one, were men. |
T342 |
631-827 |
Sentence |
denotes |
CV disease, obesity, arterial hypertension, diabetes mellitus and chronic kidney disease, although well represented in our population, were not over-represented in the group with adverse outcomes. |
T343 |
828-978 |
Sentence |
denotes |
A clinical history of neoplasia, especially an active cancer at the moment of the diagnosis, was frequently found in the group with a worse prognosis. |
T344 |
979-1147 |
Sentence |
denotes |
Recently transplanted patients presented with less fever and respiratory-related symptoms than patients who were transplanted for more than 1 and 5 years, respectively. |
T345 |
1148-1248 |
Sentence |
denotes |
Among laboratory data, lymphocytopenia and thrombocytopenia were more frequent in patients who died. |
T346 |
1249-1354 |
Sentence |
denotes |
Alteration in liver enzymes was mild and rarely observed, although mostly found in hospitalised patients. |
T347 |
1355-1442 |
Sentence |
denotes |
Whether the immunosuppression was decreased or left unchanged had no impact on outcome. |
T348 |
1443-2462 |
Sentence |
denotes |
Our study suggests that, despite well-described risk factors for poor outcome of COVID-19 infection are highly represented in our cohort, COVID-19 liver transplant patients show a clinical course not necessarily more severe to that observed in non-liver transplant patients affected by COVID-19.25–27 Publications pooling patients with different organ transplanted reported worse outcomes (in-hospital case fatality rate 24%–27%).11 13 Another publication merging surveys from European and American centres with a smaller sample than our prospective study reported 9 deaths among 39 liver transplant patients.28 Like others, we find that male patients are more prone to develop ARDS29 and have a more severe outcome.25 Although highly frequent in our cohort, CV and metabolic comorbidities were not over-represented in patients with poor outcomes.25 26 History of previous or active cancer, such as being transplanted for HCC or having cancer at the moment of the COVID-19 diagnosis, was associated with a poor outcome. |
T349 |
2463-2688 |
Sentence |
denotes |
This is in agreement with a national Chinese report on over 2000 confirmed COVID-19 cases with a history of cancer, showing them having higher risk to contract COVID-19 and poorer outcome than individuals without cancer.30 31 |
T350 |
2689-2812 |
Sentence |
denotes |
Concerning clinical presentation, patients transplanted for less than 5 years exhibited less frequently fever and dyspnoea. |
T351 |
2813-2901 |
Sentence |
denotes |
This may suggest higher immunosuppression attenuates COVID-19 typical clinical symptoms. |
T352 |
2902-3040 |
Sentence |
denotes |
GI manifestations were common (33%) in our series, which is in line with the 29% reported in solid organ transplant recipients in Spain.11 |
T353 |
3041-3222 |
Sentence |
denotes |
Lymphopenia has been reported to be predictive of poor outcome in non-transplanted COVID-19 patients.29 32 A similar trend was found also in our cohort of liver transplant patients. |
T354 |
3223-3465 |
Sentence |
denotes |
One of the key questions in the management of liver transplant patients affected with COVID-19 concerns the management of the immunosuppression.33 In our cohort, the immunosuppression was reduced in 39% of the patients and discontinued in 7%. |
T355 |
3466-3522 |
Sentence |
denotes |
Mycophenolate mofetil was the most discontinued therapy. |
T356 |
3523-3652 |
Sentence |
denotes |
The majority of the patients with COVID-19 who did not need a hospitalisation were kept on their usual immunosuppressive regimen. |
T357 |
3653-3903 |
Sentence |
denotes |
Although some reports want to suggest a potential positive role of tacrolimus as antiviral in the treatment of human coronaviruses,34 since 88% of our patients were treated with CNIs, it was not possible to assess any specific effect of this therapy. |
T358 |
3904-3930 |
Sentence |
denotes |
Our study has limitations. |
T359 |
3931-3974 |
Sentence |
denotes |
All the participating centres are European. |
T360 |
3975-4054 |
Sentence |
denotes |
It will be important to have similar prospective studies from other continents. |
T361 |
4055-4152 |
Sentence |
denotes |
We limited our analysis to the patients with a positive reverse transcription PCR for SARS-CoV-2. |
T362 |
4153-4282 |
Sentence |
denotes |
We did not include patients with typical presentation but without a microbiological confirmation due to lack of testing capacity. |
T363 |
4283-4709 |
Sentence |
denotes |
On the other hand, the NAAT assay as the recommended confirmatory test has a sensitivity in the order of 71%,35 and this could be lower in immunosuppressed population.13 Moreover, although liver transplant patients were generally well instructed to contact their transplant centre as far as COVID-like symptoms appeared, we cannot exclude a global underestimation of the total number of COVID-19 infections in this population. |
T364 |
4710-4734 |
Sentence |
denotes |
Our study has strengths. |
T365 |
4735-4845 |
Sentence |
denotes |
It is, at the time of writing, the largest prospective study of liver recipient patients affected by COVID-19. |
T366 |
4846-4949 |
Sentence |
denotes |
It is by design not a survey but a prospective acquisition of data approved by local ethics committees. |
T367 |
4950-5185 |
Sentence |
denotes |
In conclusion, in this European multicentre prospective study of liver transplant recipients, COVID-19 is associated with an overall and in-hospital case fatality rate of 12% (95% CI 5% to 24%) and 17% (95% CI 7% to 32%), respectively. |
T368 |
5186-5298 |
Sentence |
denotes |
Patients infected early after liver transplantation did not have a worse outcome and tend to have less symptoms. |
T369 |
5299-5369 |
Sentence |
denotes |
A history of cancer was more frequent in patients with poorer outcome. |